Sjogren's Syndrome Foundation: Victory

Back in April, Steven Taylor, SSF CEO, testified before the Subcommittee on Oversight of the House Committee on Ways and Means hearing. His focus was representing the Sjogren's syndrome community's reliance on OTC products, which would be excluded from health savings accounts and flexible savings accounts; unless the patient had a prescription written by their doctor for those specific over the counter products.

Can you imagine having to get a prescription for every bottle of eye drops purchased? That is, if you use funds from these HSAs/FSAs, which John and I do.

Honestly.

But thanks to Steven's testimony, the Affordable Care Act, which was passed two days ago in the House of Representatives, now includes a provision repealing limitations on the purchase of over-the counter (OTC) products.

You can read more about this outstanding advocacy effort by the Sjogren's Syndrome Foundation and see a video of Steven's Taylor's testimony on their blog, here, and you can read the written testimony here.

Excellent.